Home | CDR, PMPRB and INESSS Updates | Market Access Canada 2011

Gain improved patient access and reimbursement success by engaging key stakeholders and leading industry experts

Stakeholder relations: leading patient advocates and key provincial payers talk about their challenges and their plans for better patient access to innovative drugs
Key learnings from the sharpest minds in pharma: senior executives discuss how they tackle reimbursement issues in our panel discussion
Stay in the loop: crucial updates from INESSS, CDR, Health Canada and the provinces ensure your drug submissions stay relevant to the HTA and don't fall behind competition

Ronnie Miller
CEO
Roche

Helen Stevenson
CEO
Reformulary

Bob Nakagawa
ADM
BC Pharmaceutical Services

Doug Grant
SVP/ Head of Corporate Affairs
Bayer

Lesia Babiak
Chair of Government Affairs Council
Johnson & Johnson

David K. Lee
Director of Office of Legislative and Regulatory Modernisation
Health Canada

Olaf Koester
Director
Manitoba Health

Mark Fleming
Co-Chair
BioteCanada SEB Taskforce

Mark Findlay
VP - Access and External Relations
AstraZeneca

Durhane Wong-Reiger
CEO
Canadian Organisation of Rare Disorders

Mike Sullivan
President
Cubic Health

Russell Williams
President
Rx&D

Bob Kamino
President
Canadian Association of Healthcare and Reimbursement

George Wyatt
Managing Director
Wyatt Health Management

Bill Dempster
Director
Global Public Affairs

Ben Shenouda
President
Independent Pharmacists of Ontario

Glenn Monteith
ADM
Government of Alberta

Dr. Reiner Banken
Deputy Chief Executive Officer, External Affairs
Partnerships and Networks

Steve Long
Executive Director of Pharmaceutical Funding and Guidance
Alberta Health and Wellness

Julia Brown
National Director of Government/Community Relations

Eileen McCormack
Marketing Director
AstraZeneca

Bryan Ferguson
Partner
Applied Management Consultants

Collen Savage
CEO
Cancer Advocacy Coalition of Canada

Susan Borwick
President
Canadian Arthritis Patient Alliance

Ilona Torontali
VP
Public Affairs

Chander Sehgal
Director of Common Drug Review
CADTH

Patricia Massetti
VP, Public Affairs and Patient Access
Merck

Gregory Glenn
Senior Vice President
JBL Group

Ben Faienza
Vice President, Market Access and Government Affairs
PDCI Market Access

1 2 3 4 5 6 7 8

Join provincial payers, regulators, patient groups and pharma CEO/VPs in the highest-profile market access summit of the year

With hot panel debates, in-depth workshops and rivetting keynotes on key market access issues, this is the event for the pharma executive and government stakeholder alike.

Solidify your reimbursement strategy with these brand new eyeforpharma exclusives for 2011

Become a PLA pro with the Definitive Guide to PLAs Workshop
CEO keynote from Ronnie Miller (Roche)
Look into the future of private payers with Helen Stevenson
Official INESSS and pCODR updates
An exclusive insight into Patient advocacy groups and their goals
Find out the latest on the Comprehensive Economic and Trade Agreement
Health Canada's modernisation of food and drug act and how that affects your reimbursement strategy

Have a look at our stellar speaker line-up here

This is a fantastic event for a market access team to participate in. The ever changing landscape of access requires tremendous attention in order to understand the tactics and strategies that will lead to building a successful plan. This event does a terrific job of touching on all major issues related to access and has fueled terrific discussions at our company, helping us to ensure our approach and value proposition meet the needs of payers.

Damon Goodwin, External Affairs Manager, Boehringer Ingelheim.

Check Out One of the Hot Discussion Panels from Last Year

An unmissable opportunity to drive your business ahead of competitors with...

Bob Nakagawa and Glenn Monteith on their future plans and how pharma can align their strategies for reimbursement success

Pharma’s elite including Doug Grant, SVP, Bayer on how they deal with market access challenges

Gain the competitive edge in your drug submissions with Official updates from INESSS, PCODR and CDR

Take the first steps to an fantastic 2012 by downloading the brochure here

Still not sure if this summit is for you? ...

94% of the 2010 delegates plan to attend the 2011 Market Access summit in October. With outstanding presentations from the CDR, PMPRB, CCO, Rx&D as well as industry best practice examples from Bayer, Roche, Johnson & Johnson (J&J), Bristol Myers Squibb (BMS), Takeda and AstraZeneca (AZ) it's clear to understand why.

If you missed the 09 Market Access summit. Catch up on presentations by Doug Grant, VP, Corporate Affairs, Bayer, Krista Scaldwell, VP Market Access, BMS, Brian O'Rouke, VP, CDR and Barbara Ouellet, Executive Director, PMPRB here: 09 Presentation.